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Extent of Lumpectomy for Breast Cancer After Diagnosis by
Stereotactic Core Versus Wire Localization Biopsy
Saif S. Al-Sobhi, MD, Mark A. Helvie, MD, Helen A. Pass, MD, and Alfred E. Chang, MD
Background: Stereotactic core biopsy of mammographically defined breast abnormalities is an
alternative to wire localization biopsy. The purpose of this study was to evaluate the extent of
lumpectomy in patients diagnosed by stereotactic core versus wire localization biopsy.
Methods: A total of 67 consecutive patients diagnosed with invasive cancers or ductal carcinoma
in situ (DCIS) were retrospectively reviewed. Thirty-four were diagnosed by core biopsy and the
remaining 33 by wire localization biopsy.
Results: Approximately 65% of patients subsequently had breast-conserving surgical therapy.
Seventy-nine percent of patients undergoing wire localization biopsies had positive surgical mar-
gins. Achievement of negative surgical margins for lumpectomies performed after wire localization
or stereotactic core biopsies was 100% and 89%, respectively, which was not significantly different.
However, the total volume of breast tissue removed for breast conservation in patients undergoing
lumpectomy after wire localization versus core biopsies was 183 cm3 and 104 cm3, respectively,
which was significantly different (P  .003).
Conclusions: Diagnosis by stereotactic core biopsies resulted in less tissue removal to achieve
margin-negative lumpectomies for breast conservation. Stereotactic core biopsy is the method of
choice for biopsying nonpalpable, suspicious breast lesions.
Key Words: Breast cancer—Mammography—Biopsy—Breast conservation.
The use of annual screening mammography has in-
creased the detection of nonpalpable breast lesions re-
quiring biopsy. It is estimated that approximately
500,000 of these lesions are detected annually in the
United States.1 Most of these mammographic abnormal-
ities prove to be benign, but approximately 15% are
found to be malignant.2 There are different biopsy tech-
niques available for studying these nonpalpable lesions.3
Stereotactic larger core biopsy, an alternative method
to diagnose mammographic abnormalities, was first de-
scribed in 1990 by Parker and coworkers.4 This biopsy
technique has been adopted by many practitioners. It
costs less than a surgical biopsy5–7 and has been reported
to have a high sensitivity and specificity rate in diagno-
sis.8,9 However, there are some difficulties in differenti-
ating between atypical ductal hyperplasia and breast car-
cinoma.
Wire localization biopsy of nonpalpable breast lesions
detected mammographically has been the “gold stan-
dard” method for the last three decades. It remains the
only technique available in centers where stereotactic
core facilities are not available. It is more invasive than
stereotactic core biopsy, because it requires an operative
approach and leaves a scar.
In this report, we compared the utility of these biopsy
procedures in patients subsequently diagnosed with
breast cancer. Specifically, we examined the surgical
outcomes of patients who went on to receive lumpecto-
mies for breast conservation.
MATERIALS AND METHODS
Subjects
A total of 337 patients identified as having moderately
to highly suspicious mammographic lesions underwent
biopsies during the period from April 1996 to April 1998
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at the University of Michigan Medical Center. Of those
patients, 147 and 190 patients had either stereotactic core
or wire localization biopsies, respectively. A total of 67
of these patients (20%) who were found to have invasive
or noninvasive cancers made up the group analyzed in
this study. Patients diagnosed with lobular carcinoma in
situ only were excluded from the study. Four surgical
oncologists within the Division of Surgical Oncology
performed the wire localization biopsies and definitive
surgical procedures. The decision whether to perform a
wire localization biopsy versus a stereotactic core biopsy
was made jointly by the surgeons in consultation with the
mammographers. If a mammographic lesion could be
biopsied by either technique, the surgeon presented the
options to the individual patient to allow the patient to
make an informed choice. In our early experience with
the stereotactic core biopsy apparatus, fewer attempts
were made by the mammographers to biopsy microcal-
cifications in contrast to mass lesions. This was not the
case in the latter part of the study period after more
experience with the technique had been acquired. The
decision of what definitive surgical procedure should be
performed (breast conservation versus mastectomy) was
made by the patient after consultation with the multidis-
ciplinary team of healthcare providers at the Breast Care
Center of the University of Michigan Cancer Center.
Medical records were reviewed for patient demograph-
ics, mammographic findings, pathological characteris-
tics, and the definitive surgical procedures.
Wire Localization
The skin surface closest to the lesion was chosen, The
breast was compressed with the patient in a sitting posi-
tion, and an alphanumeric fenestrated paddle was placed
over the suspicious abnormality. Coordinates were trans-
ferred onto the skin, and a 21-gauge hook-wire apparatus
(Kopans Spring Hook Localizer Needle, Wire Loc Cook,
Bloomington, IN) was inserted into the breast following
local anesthesia with 1% lidocaine. After needle place-
ment, orthogonal views were obtained to determine the
correct depth. A hook-wire was then deployed through
the needle, which was subsequently withdrawn. The
hook-wire usually was placed with the reinforced portion
within the lesion and the tip of the wire extending be-
yond it. Craniocaudal and lateral mammographic views
were obtained with the hook-wire in place. These views
were labeled and submitted with the patient to the sur-
geon for subsequent operative procedure. The excisional
biopsy was performed in an operating room suite using a
combination of a local anesthetic and intravenous seda-
tion. Specimen radiography was performed to confirm
lesion excision.
Stereotactic Core Biopsy
The breast was suspended through the aperture of a
dedicated prone digital breast biopsy table. Following
compression and identification of the suspicious abnor-
mality, stereotactic pairs of images were obtained at 15°
off center. The suspicious lesion was identified on both
stereotactic images on a video terminal, and its location
was determined using the software package employing
geometric formulas that assess the relative movement of
the index lesion on the stereotactic pairs. A 14- or 11-
gauge vacuum-assisted needle (Core Needles Biopsys
Mammotome TM needle, Biopsys Medical, Irvine, CA)
was then inserted into the compressed breast at the cor-
rect coordinates following local anesthesia with lido-
caine. A “prefire” stereotactic pair was obtained to doc-
ument correct needle location. This was followed by
“postfire” stereotactic pairs after the needle had been
advanced mechanically through the lesion. Following
confirmation of needle location, vacuum-assisted core
biopsy samples of the lesion were obtained. Generally, at
least 12 samples were taken. If calcifications were
present, a specimen radiograph was obtained to confirm
retrieval. Mammographic/pathologic concordance was
determined when the pathology results were available.
Discordant results led to recommendation for wire-local-
ized surgical biopsy.
Local Breast Excision Techniques
Wire localization biopsies were performed for diag-
nostic purposes. A radius of at least 1 cm to 2 cm of
breast tissue from the wire was excised. A specimen
radiograph was performed to confirm that an adequate
sample of tissue had been obtained.
In the setting of a confirmed diagnosis of malignancy
(i.e., after stereotactic core or wire localization biopsy) a
margin-negative lumpectomy was attempted in patients
deemed to be candidates for breast conservation. This
entailed a wire localization lumpectomy for patients pre-
viously diagnosed by stereotactic core biopsy. The tech-
nique is similar to that described above in which breast
tissue was excised in an effort to achieve negative sur-
gical margins. For patients who had had a prior wire
localization biopsy in whom the malignant lesion in-
volved the surgical margin, a re-excision lumpectomy
was performed. This procedure involved excising the
previous biopsy skin incision in continuity with the un-
derlying breast tissue surrounding the biopsy site, with
an effort made not to enter the biopsy cavity.
All breast excision specimens were inked for evalua-
tion of the margin status. Tumor cells present at the
margin or less than 3 mm away from the margin were
considered positive.
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Statistical Analysis
Comparisons were analyzed by the Student’s t-test.
These analyses were performed with the aide of the
StatView statistical software (Abacus Concepts, Inc.,
Berkeley, CA).
RESULTS
Mammographic Findings, Biopsy Results, and
Surgical Therapy
A total of 67 patients were evaluated in this study; 34
underwent stereotactic core biopsy and 33 had wire lo-
calization biopsy. The median ages of the patients diag-
nosed by stereotactic core and wire localization biopsy
were 59 years (range, 43–70 years) and 58 years (range,
31–85 years), respectively, and were not statistically
different. Table 1 summarizes the mammographic find-
ings of both groups. In the stereotactic core biopsy group
there were 27 (79%) patients with masses with or with-
out microcalcifications and 7 (21%) with microcalcifica-
tions only. By contrast, in the wire localization group, 18
(54%) patients presented with masses with or without
microcalcifications, 14 (42%) with microcalcifications
only, and 1 (4%) with architectural distortion.
In the stereotactic core biopsy group, there were 26
(77%) patients who had invasive carcinoma, 5 of whom had
an intraductal component (Table 1). Eight patients were
diagnosed as having DCIS, with two of these patients
having evidence of microinvasion. In the wire localization
group, 20 (60%) patients had invasive carcinoma, of whom
5 had an intraductal component; and 13 (39%) patients had
DCIS without evidence of microinvasion.
The correlation between the mammographic findings
and the subsequent biopsy results is summarized in Table
2. Among the 45 patients who presented with a mass
with or without evidence of microcalcifications, 40
(89%) were found to have infiltrating ductal carcinoma
with or without an intraductal component. By contrast,
among the 21 patients who presented with microcalcifi-
cations, 16 (76%) were diagnosed with DCIS.
The operative procedures performed after biopsy are
summarized in Table 3. Among the 34 patients diagnosed
by stereotactic core biopsy, 33 patients had their definitive
surgical procedure performed at the University of Michi-
gan. Nineteen (57%) of these patients underwent breast
conservation; the remaining 14 (43%) had mastectomies.
Among the 33 patients diagnosed by wire localization bi-
opsy, six patients had no further surgery at the University of
Michigan. Among these six patients, four had DCIS with
negative surgical margins and went on to receive radiother-
apy; one patient had DCIS with a focally positive surgical
margin and had radiotherapy without re-excision; and one
patient had positive margins and went on to have surgical
therapy at another institution. The remaining 27 patients of
the 33 diagnosed by wire localization biopsy had a subse-
quent surgical procedure performed (see Table 3). Of the 32
patients diagnosed by wire localization biopsy and treated at
the University of Michigan, 23 (72%) underwent breast
conservation and the remaining nine had mastectomies.
There was no significant difference between the two biopsy
techniques in the proportion of patients undergoing breast
conservation ( 2, P  .17). Combining all 65 patients
diagnosed and treated at our institution, 42 (65%) of pa-
tients underwent breast conservation.
Surgical Margins in Patients Undergoing Breast
Conservation
The status of the surgical margins among the 33 pa-
tients undergoing wire localization biopsy was evaluated.







No. (%) No. (%)
Mammographic findings
Mass 23 (68) 14 (42)
Microcalcifications 7 (21) 14 (42)
Mass with microcalcifications 4 (11) 4 (12)
Architectural distortion — 1 (4)
Histologic findings
IDC 21 (62) 15 (45)
IDC  DCIS 5 (15) 5 (15)
DCIS 6 (18) 13 (39)
DCIS with microinvasion 2 (5) —
DCIS, ductal carcinoma in situ; IDC, infiltrating ductal carcinoma












IDC 27 1 7 1
IDC  DCIS 6 4 0 0
DCIS 3 16 0 0
DCIS with microinvasion 1 0 1 0
IDC, infiltrating ductal carcinoma; DCIS, ductal carcinoma in situ.
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Twenty-six (79%) of these patients had positive surgical
margins with the wire localization biopsy specimen.
Among these 26 patients, 16 proceeded to have a subse-
quent re-excision lumpectomy for breast-conserving
therapy. Re-excision lumpectomy resulted in negative
surgical margins in all 16 (100%) of these latter patients
(Table 4). Nineteen patients who had stereotactic core
biopsies proceeded to a lumpectomy for breast-conserv-
ing surgery. Seventeen (89%) of these 19 patients had
negative surgical margins (see Table 4). Among the two
patients with positive margins, one underwent a re-exci-
sion lumpectomy with negative margins and the other
patient had a mastectomy. The mastectomy was per-
formed because a second primary cancer (chondrosarco-
ma) in addition to an invasive ductal carcinoma was
found within the lumpectomy specimen.
Extent of Lumpectomy
We estimated the extent of lumpectomy by calculating
the volume of tissue that was excised in cubic centime-
ters (cm3). These volumes were determined from the
pathology reports, where the sizes of the tissues removed
were recorded in three dimensions. For re-excision
lumpectomies, the dimensions of the entire specimen,
which excluded the biopsy cavity, were used to calculate
the volume. The volumes of tissue excised for patients
undergoing breast conservation are summarized in Table
4. The mean volume of tissue removed with the wire
localization biopsy was 38 cm3. For those patients un-
dergoing subsequent lumpectomy, the mean volume was
143 cm3. We combined the amount of tissue removed in
each patient by adding the volume removed at wire
localization biopsy plus the subsequent lumpectomy vol-
ume to derive a mean total volume of breast tissue
removed, which was 183 cm3. For purposes of compar-
ison, the mean volume of tissue removed by lumpectomy
after core biopsy was 104 cm3. When this latter volume
of tissue is compared with the total amount of tissue
removed for patients undergoing wire localization biopsy
followed by lumpectomy, it is clear that the patients who
initially had a core biopsy had significantly less breast
tissue removed (P  .003).
Total Number of Surgical Procedures per Patient
The number of surgical procedures performed in the
operating room suite per patient was calculated for the
groups biopsied by stereotactic core versus wire local-
ization biopsy. For the stereotactic core group, there
were 38 surgical procedures performed resulting in a
mean  SD of 1.1  0.3. For the wire localization
biopsy group, there were 61 surgical procedures per-
formed, which resulted in a mean  SD of 1.8  0.4; and
was significantly increased (P  .001) compared to core
biopsy. For the subset of patients undergoing breast
conservation after stereotactic core biopsy, there were 23
surgical procedures performed, resulting in a mean of
1.2  0.4 procedures per patient. For the subset of
patients diagnosed by wire localization biopsy who sub-
sequently underwent breast conservation, there were 37
procedures performed, which calculated to a mean of
2.1  0.2 procedures per patient. This was significantly
greater (P  .0001) than patients having stereotactic core
biopsies.
DISCUSSION
The wide use of screening mammography has resulted
in the detection of increasing numbers of nonpalpable
breast lesions. The recent recommendations by the Na-
tional Cancer Institute and American Cancer Society that
all women over 40 years of age consider annual screen-
ing mammograms will add to these numbers. The man-
agement of these lesions varies according to the level of
suspicion of malignancy identified by the mammogra-
pher.







No. (%) No. (%)
Lumpectomy 4 (12) 10 (37)
Lumpectomy  ALND 15 (45) 6 (22)
ALND 2 (7)
Simple mastectomy 6 (18) 4 (15)
Modified radical mastectomy 8 (24) 5 (19)
Total 33 (100) 27 (100)
ALND, axillary lymph node dissection.










Wire localization biopsy 24 6 (25) 38 (29)
Lumpectomy after wire
localization biopsy






19 17 (89) 104 (59)c
a Volumes expressed in cm3  standard deviation (SD).
b Total volume of tissue removed  wire localization biopsy vol-
ume  subsequent lumpectomy volume
c P  .0001 compared to Group 1; not significantly different com-
pared to Group 2; P  .003 compared to Group 3.
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The College of Radiology Breast Imaging Reporting
and Data System (BI-RADS) has devised a useful clas-
sification scheme for characterizing mammographic
findings that has been widely adopted by mammogra-
phers.10 A mammogram that does not demonstrate an
abnormality is classified as BI-RADS 1. A mammogram
that identifies a benign finding (i.e., calcified fibroade-
noma) is classified as BI-RADS 2. Mammographic le-
sions that are probably benign (BI-RADS 3) and have a
less than 2% probability of being malignant should un-
dergo short-term follow-up mammography rather than
biopsy. Suspicious lesions (BI-RADS 4) do not have all
the characteristic features of breast cancer but are suffi-
ciently suspicious to recommend biopsy. These lesions
generally are considered for stereotactic core biopsy be-
cause a definitive benign diagnosis would eliminate the
need for a surgical biopsy. Lesions highly suggestive of
malignancy (BI-RADS 5) have characteristic features of
cancer, and have a high probability of being cancer.
Several reports have documented these lesions to be
cancers in approximately 80% of cases.9 The role of
stereotactic core biopsy has been controversial in this
category of patients. Because of the high index of sus-
picion of these lesions, some clinicians recommend an
open biopsy to obtain a definitive diagnosis, because a
nondiagnostic reading of a stereotactic core biopsy
would not avoid the need for a subsequent open biop-
sy.11–13 Our study, as well as reports by others, suggests
that there are several reasons why stereotactic core bi-
opsy may be advantageous for even the highly suspicious
lesions.9–14
From the cost standpoint, Yim et al.1 and Whittin et
al.15 have reported that stereotactic core biopsy reduced
the number of surgical procedures performed per patient.
We observed the same phenomenon when analyzing the
entire group of patients who had core biopsies compared
to wire localization biopsies. This has translated to a cost
reduction ranging from $1000 to $2000 per patient for
individuals undergoing stereotactic core biopsy.1,15,16
One area in which this cost reduction is realized is the
high incidence of positive surgical margins associated
with wire localization biopsies. In our series, we ob-
served a 79% incidence of positive margins in wire
localization biopsy specimens. This is consistent with
other reported series, in which the finding of positive
surgical margins after wire localization biopsy has
ranged from 55% to 83%.1,15,17 No attempt at achieving
negative margins, such as the use of “touch preps,” was
made because these were diagnostic procedures. By con-
trast, the incidence of positive surgical margins for breast
lumpectomy after a diagnosis was established by stereo-
tactic core biopsy was significantly lower. In this setting,
we observed an 11% incidence of positive margins.
Whittin et al. reported a 29% incidence of positive mar-
gins in similar patients.15 In the series reported by Yim et
al., where patients with DCIS only were excluded, the
incidence of positive margins after stereotactic core bi-
opsy was 6%.1 These observations indicate that a defin-
itive lumpectomy can be performed as a single procedure
in the majority of cases when the diagnosis has been
established by core biopsy. The use of touch preparation
cytology at the time of lumpectomy may be useful in
increasing the rate of negative-margin specimens.18
In patients who are potential candidates for breast-
sparing surgery, resection of the primary tumor with the
least amount of tissue removal and achievement of neg-
ative surgical margins obviously is desirable. We have
been able to document that a reduced volume of tissue is
removed at the definitive surgical procedure in patients
diagnosed by stereotactic core biopsy compared to the
total volume of tissue removed in patients diagnosed by
wire localization biopsy. The volume of tissue removed
for lumpectomy after core biopsy was significantly
greater than the volume of the initial wire localization
biopsy. Similar results were observed by Whittin et al.15
Moreover, the volume of tissue removed for patients
undergoing re-excision after wire localization biopsy
was equivalent to that removed for lumpectomy after
core biopsy. This translated to a significantly greater
total volume of tissue removed in the wire localization
biopsy group than in the core biopsy group.
Some clinicians advocate performing definitive
lumpectomies or segmental mastectomies on highly sus-
picious mammographic lesions (BI-RADS 5), which
would result in obtaining a diagnosis of malignancy as
well as achieving a negative surgical margin in the ma-
jority of patients with just one procedure.17,18 However,
10% to 20% of patients in this group will be found to
have no malignancy and thus would have undergone an
unnecessarily more aggressive procedure to achieve a
diagnosis. The patients determined to have invasive can-
cers still will require a staging procedure such as an
axillary lymph node dissection or lymphatic mapping.
Hence, the number of surgical procedures per patient will
not be reduced in that subset of patients. Moreover,
lymphatic mapping may be compromised by the large
volume of breast parenchyma removed at the initial
lumpectomy procedure. These issues argue in favor of
obtaining a tissue diagnosis up front with the least inva-
sive procedure, such as an image-guided needle or core
biopsy. One concern with this approach is the possible
implantation of tumor cells along the needle or core
track. Longer follow-up will be needed to determine if
there is a higher incidence of in-breast recurrences in
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patients undergoing breast conservation surgery initially
diagnosed by image-guided needle or core biopsy. When
we perform a definitive lumpectomy, we excise the skin
puncture site and track at the same time whenever pos-
sible. This requires close interaction with the mammog-
rapher so that core biopsy sites are placed appropriately
at locations that will traverse the least amount of tissue to
the lesion. Subsequent lumpectomy by the wire localiza-
tion technique then requires placement of a wire along
the previous core or needle biopsy track.
Cooperation among surgeons, radiologists, and pri-
mary physicians is very important in the management of
patients with mammographically detected lesions. Ac-
cordingly, the best method for following or biopsying
these lesions should be determined by this team. The
advantages and disadvantages should be explained to the
patient. We favor stereotactic core biopsy for suspicious
(BI-RADS 4) and highly suspicious (BI-RADS 5) sus-
picious mammographic lesions. This approach would
result in a reduction of the amount of breast tissue
removed at the time of definitive lumpectomy for pa-
tients desiring breast conservation, with the advantage
of a potentially improved cosmetic result. In addition,
stereotactic core biopsy is a more cost-effective method
of making a diagnosis of a mammographically detected
lesion.
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